Impact of cortactin in cancer progression
2023-04-04
(Press-News.org)
“Cortactin (also known as EMS1 or CTTN) is expressed broadly in a variety of cancers [...]”
BUFFALO, NY- April 4, 2023 – A new editorial paper was published in Oncotarget's Volume 14 on March 21, 2023, entitled, “Impact of cortactin in cancer progression on Wnt5a/ROR1 signaling pathway.”
In this editorial, researchers Kamrul Hasan and Thomas J. Kipps from the University of California discuss cortactin—an intracellular cytoskeletal protein that can undergo tyrosine phosphorylation upon external stimulation and promote polymerization and the assembly of the actin filament that is required for cell migration. Upon stimulation, cortactin binds and activates actin related protein Arp2/3 complex, a de novo actin nucleator that can induce F (filamentous)-actin polymerization [1, 2].
Cortactin (also known as EMS1 or CTTN) is expressed broadly in a variety of cancers, for which it plays an apparent role in cellular protrusions, which include lamellipodia and filopodia formation to promote migration and metastasis. Moreover, cortactin is expressed in (i) primary chronic lymphocytic leukemia (CLL) and primary breast-cancer cells, (ii) at least 15% of metastatic breast carcinomas, and (iii) CLL or breast cancer cell lines [3, 4]. In structure, cortactin contains a SH3 domain that allows it to bind characteristic motifs (-P-X-X-P-), which can be found in the proline-rich-domains (PRD) of other proteins, including receptor-tyrosine-kinase-like orphan receptor 1 (ROR1) [1, 3, 4].
“We have found (as have other investigators) that ROR1 is expressed by a variety of human cancers, which include CLL and breast cancer, suggesting that ROR1 may play a role in cancer pathogenesis [3–5].”
Continue reading the editorial paper: DOI: https://doi.org/10.18632/oncotarget.28386
Correspondence to: Thomas J. Kipps
Email: tkipps@ucsd.edu
Keywords: cortactin, Wnt5a, ROR1, migration, metastasis
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
LabTube
Soundcloud
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact: media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-04-04
Male beetles face a trade-off between competing with other males for mating opportunities and repairing damage to their sperm DNA, according to a study publishing April 4th in the open access journal PLOS Biology by Mareike Koppik from Uppsala University, Sweden, and colleagues.
Mutations in sperm and egg DNA can reduce the survival and fitness of offspring, so animals use a variety of repair and maintenance mechanisms in their reproductive cells. However, previous research has shown that sperm DNA has more mutations than egg DNA in a variety of ...
2023-04-04
The prevalence of multimorbidity, the co-occurrence of two or more chronic conditions, varies depending on exactly how it is defined. And the healthcare costs associated with many disease combinations cost more together than the sum of each individual disease. Those are the conclusions of two new studies, publishing April 4th in the open access journal PLOS Medicine, that broadly analyze the concept and costs of multimorbidity.
Multimorbidity is increasing in prevalence due to improved survival from chronic diseases and population aging, and now poses major challenges to healthcare systems worldwide. ...
2023-04-04
SCI Canada Awards 2023 dinner, seminar and presentations to take place on 18 April in Toronto
Seminar theme is ‘Unlocking the potential of science talent enabling impact on Canada’s economic growth’
Award winners include the first indigenous community members
Dr Paul Smith, Perimeter Institute for Theoretical Physics, will receive the 2023 Canada Medal
A panel representing the best of Canadian science and industry will discuss its role in boosting economic growth at a special awards event on 18 April in Toronto.
Winners of the 2023 SCI Canada Awards include ...
2023-04-04
CAMBRIDGE, MA -- Materials known as metal-organic frameworks (MOFs) have a rigid, cage-like structure that lends itself to a variety of applications, from gas storage to drug delivery. By changing the building blocks that go into the materials, or the way they are arranged, researchers can design MOFs suited to different uses.
However, not all possible MOF structures are stable enough to be deployed for applications such as catalyzing reactions or storing gases. To help researchers figure out which MOF structures might work best for a given application, MIT researchers have developed a computational approach that allows ...
2023-04-04
Sexual selection provides an answer to the existence of lavishly ornate signals in animals, but not to the question of why such signals are attractive, why do females prefer the extravagant plumage of peacocks? As part of an international team, researchers at Eötvös Loránd University (ELTE) have shown that the reason is not the presumed wasteful cost of ornaments, as honest signals need not have to be costly at all as long as cheaters would have to pay to fake them. Researchers have developed a general formula to calculate honest equilibrium in any model, independent of the cost ...
2023-04-04
RIVERSIDE, Calif. -- A University of California, Riverside, study has identified the biological underpinnings of a reproductive disorder caused by the mutation of a gene. This gene mutation also causes Fragile X Syndrome, a leading genetic cause of intellectual impairment and autism.
The researchers found mutations of the Fragile X messenger ribonucleoprotein 1 gene, or FMR1, contribute to premature ovarian failure, or POF, due to changes in neurons that regulate reproduction in the brain and ovaries. The mutation has been associated with early infertility, due ...
2023-04-04
PHILADELPHIA — Chronic kidney disease (CKD) is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. Despite the disease’s prevalence—10 percent of individuals across the globe suffer from CKD—there are limited tools for measuring cardiac risk for CKD patients, until now. A new proteomic risk model for cardiovascular disease was found to be more accurate than current methods of measuring cardiac risk, according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania. The study published today in the European Heart Journal.
The Penn researchers developed ...
2023-04-04
How Little-Known Brain Cells Tamp Down Overexcited Neurons During Acute Stress
A brimming inbox on Monday morning sets your head spinning. You take a moment to breathe and your mind clears enough to survey the emails one by one. This calming effect occurs thanks to a newly discovered brain circuit involving a lesser-known type of brain cell, the astrocyte. According to new research from UC San Francisco, astrocytes tune into and moderate the chatter between overactive neurons.
This new brain circuit, described March 30, 2023 in Nature Neuroscience, plays a role in modulating attention and perception, and may hold a key to treating attention disorders like ...
2023-04-04
Worcester, Mass. – April 4, 2023 – WPI Researcher Kristen Billiar has been awarded $429,456 from the National Institutes of Health to investigate how stretching and blood flow can inhibit or encourage cardiovascular cells to populate and grow in tissue-engineered heart valves.
The three-year project focuses on experimental valves that are not yet used in humans, and the work will expand understanding about how mechanical forces propel cells in the body.
“Existing heart valves have drawbacks, ...
2023-04-04
Articles
Disclosing Conflicts of Interest to Potential Research Participants: Good for Nothing?
Inmaculada de Melo-Martín
The growing commercialization of science has raised concerns about financial conflicts of interest. Evidence suggests that such conflicts threaten the integrity of research and the well-being of research participants. Trying to minimize these negative effects, federal agencies, academic institutions, and publishers have developed conflict-of-interest policies. Among such policies, recommendations or requirements to disclose financial COIs to potential research participants ...
LAST 30 PRESS RELEASES:
[Press-News.org] Impact of cortactin in cancer progression
